AN

Ajoyendra Nath Chattopadhyay

Active Director Designated Partner DIN 10241409
DIN 10241409 First appointment Jul 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Ajoyendra Nath Chattopadhyay

Data last updated:

Ajoyendra Nath Chattopadhyay is a Designated Partner at Asian Institute Of Immunology & Rheumatology Llp (since 2023). The company operates in Healthcare.

DIN 10241409
Primary Designation Designated Partner
Industry Healthcare
First Appointment 17 Jul 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner17 Jul 20232023Active

Board colleagues of Ajoyendra Nath Chattopadhyay

Directorship timeline

Open interactive timeline →
Asian Institute Of Immunology & Rheumatology Llp
Premium access

Shareholding and investment profile for Ajoyendra Nath Chattopadhyay

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajoyendra Nath Chattopadhyay

Ajoyendra Nath Chattopadhyay currently holds 1 directorship: Asian Institute Of Immunology & Rheumatology Llp (Designated Partner, since 17 Jul 2023).

Ajoyendra Nath Chattopadhyay was first appointed on 17 Jul 2023 as Designated Partner at Asian Institute Of Immunology & Rheumatology Llp.

The current boards of Ajoyendra Nath Chattopadhyay's companies include Parthajit Das (Asian Institute Of Immunology & Rheumatology Llp), Somnath Chatterjee (Asian Institute Of Immunology & Rheumatology Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available